B.E Announced List 10th

7/24/2019 B.E Announced List 10th

1/16

Trang 1 / 16

B Y T CNG HA X HI CH NGHA VITc lp - T do - H! p!"c

#$%& o' () *+d$c$+ !,+ B./ p0oo' doc1*+& 234&!5

______________________________

o 60od1c& ,*+ Ac&$+ %17%&,c+ %&0+8&!9coc+&0,&$o do%,8+ 'o0* p,c:$8-%$;+ 0+8$%&0,&$o o M,1',c&10+0

1 Bisoprolol fumarat tablet bao phim Hp 1 v, 3 v x 10 vin VD-11!-11

" Bisoprolol fumarat tablet bao phim Hp 1 v, 3 v x 10 vin VD-11#-11

3

$00m%

tablet &'i bao phim Hp 10 v x vin VD-11$0-10

( )*+.V/D 1"$

1"$m%

Hp 10 %i x 3%

$ lamex $00 Hp 1" %i x "% VD-10011-10

H Ni, ngy 23 thng 01 nm

(Ban hnh km theo Quyt nh s 241/Q-BYTngy 23/01/2015ca B t!"ng B # t$

Bisolo2$m%

)n% t4 56HH nite&/nternational 7harma8

Bisolo2",$m%

)n% t4 56HH nite&/nternational 7harma8

tablet &'i bao phim9:).;:)/6 $00

)larithrom42in )n% t4 )< ph=n D>?2 [email protected]

)efuroxim 1"$m%A&>i &Cn%)efuroxim axetil1$0,(m%

poE&er pha hFn&G2h un% VD-13#0"-11

)n% t4 2< ph=n D>?2 5run%>In% V/D/7H:8

:moxi2illintrih4&rat t>In%J>In% $00m%:moxi2illinK)lavulanatepotassium Lsili2one &ioxi&t>In% J>In%",$m% :2i&)lavulani2

poE&er pha hFn&G2h un% )n% t4 2< ph=n D>?2 HMuNian%8


2/16

Trang 2 / 16


O:6/:5 $00

$00m%

tablet &'i bao phim Hp " v x $ vin

P

"0m%

tablet bao phim VD-1"1"-1"

! 9/D:65/6 tablet &'i bao phim VD-1!31#-13

# B*6:;:7/; $ *nalapril tablet Hp 3v x 10 vin V6-1"!P!-11

10 Q./9:Q "$0m%

"$0m%

tablet bao phim Hp 1 v x 10 vin V6-#!(#-10

11 )efuroxim axetil $00 tablet &'i bao phim Hp " v x $ vin VD-1"#"-10

1" Oento2efix "00 )efixim "00m% tablet &'i bao phim Hp 10 v x 10 vin VD-##"(-0#

13100m%

Hp 10 %i, 1( %i x "% VD-P0!-0#

1( phaxim "00 )efixim trih4&rat"00m%

2apsule 2Rn% Hp 1 v x 10 vin VD-P3-0#

1$ Hapa2ol sSi 7ara2etamol$00m%

tablet sSi bTt Hp ( v x ( vin VD-"0$P1-1(

)efuroxim &>i&Cn% )efuroximaxetil

VD-!11-0# )n% t4 2< ph=n D>?2 5run%>In% V/D/7H:8

;istate "0 :torvastatin "0m%&>i &Cn%:torvastatin 2al2i

trih4&rat

Hp 3 v x 10 vinKHp 10 v x 10 vin8

)n% t4 )< ph=n D>?2 ph@m:mphar2o 8U8:8

:moxi2illin $00m%&>i &Cn%amoxi2illintrih4&rat :2i&)lavulani2 1"$m%&>i &Cn% Wali2lavulanat

Hp 1 tXi x " v x Pvin8

)n% t4 )< ph=n &>?2 ph@m9inh DYn8

$m% Berlin - )hemie :N Nerman48

)efuroxim "$0m%&>i &Cn%)efuroxim axetil

Uan&oZ NmbH8

)efuroxim $00m%&>i &Cn%)efuroxim axetil

$00m%)n% t4 )7 D7 5run% >In%V/D/7H:8

"00m%

)hi nh[nh )n% t4 2< ph=n

:rmephar2o- Q\ n%hi]p &>?2ph@m 1$08

)efixim pha2e 100 )efixim trih4&rat Bt pha hFn &G2hun%

)n% t4 )< ph=n D>?2 ph@m5run% >In% "$8

)n% t4 )< ph=n D>?2 ph@m5run% >In% "$8

)n% t4 56HH 95V D>?2ph@m DHN8


3/16

Trang 3 / 16


1 tablet &'i bao phim Hp " v x P vin

1P tablet &'i bao phim

1! Uoruxim "$0 "$0m% tablet bao phim Hp 1 v x 10 vin VD-"0$!-1(

1# 9etovan2e tablet &'i bao phim Hp 3 v x 10 vin VD-1(##0-11

"0 9e2am 1$ tablet bao phim VD-#3"(-0#

"1 :torhasan "0

"0m%

tablet bao phim VD-#0!$-0#

"" tablet bao phim VD-1P3!0-1"

"3 tablet bao phim Hp $ v x 10 vin VD-13$#3-10 )n% t4 2< ph=n 74mephar2o8

"( tablet bao phim Hp " v x 1( vin VD-1!$33-13

:u2lanit4l 1% :moxi2illintrih4&rat 1 00(,$m% At>In% J>In%:moxi2illin Whan!P$m% :2i&2lavulani2 1"$m%K

VD-11#(-10 )n% t4 2< ph=n D>?2 ph@m5iphar2o8

:u2lanit4l "$m% :moxi2illintrih4&rat $P(m%At>In% J>In%:moxi2illin Whan$00m% Wali2lavulanat1(!,P$m% At>In%J>In% a2i&2lavulani2 1"$m%

Hp " v x P vinKHp " v x 10 vin

VD-11#$-10 )n% t4 2< ph=n D>?2 ph@m5iphar2o8

)efuroxim "$0m%A&>i &Cn%)efuroxim axetilK

)n% t4 2< ph=n D>?2 ph@m:m Vi8

9etforminh4&ro2lori& $00m%v' Nliben2lami&$m%K

)n% t4 2< ph=n &>?2 ph@m5r>^n% 5hT8

9eloxi2am 1$ m% Hp 1 v, 3 v, 10 v x10 vin

)n% t4 2< ph=n &>?2 ph@m:mphar2o 8U8:8

:torvastatin "0m%At>In% J>In%:torvastatin 2al2itrih4&rat "1,! m%

Hp 3 v, 10 v x 10vin

)n% t4 56HH Hasan -Dermapharm8

:mfarex $00 )larithrom42in $00m% Hp 1 v x P vinHp 3 v x 10 vin

)n% t4 2< ph=n D>?2 ph@m:mphar2o 8U8:8

74metpha%e-$00 9etformin H)l $00m%

/rbesartan Uta&a300m%

/rbesartan300m%

)n% t4 lin &oanh 56HHUta&a Vi]t 6am8


4/16

Trang 4 / 16


"$$m%

tablet VD-##P-0#

"$m%

tablet trn bao phim Hp 3 v x 10 vin VD-1PP"-1"

"P tablet Hp 10 v x 10 vin VD-1"1#-10

"!3$m%

tablet bao phim8 VD-1"01-10

"#30m%

VD-0($-0! )n% t4 2< ph=n 74mephar2o8

301$0m%

tablet bao phim Hp " v x 1( vin VD-1$#0$-11

31 )lo2ar&i%el

P$m%

tablet bao phim VD-1"!#1-10

3"

$00m%

tablet &'i bao phim VD-130P#-10

33100m%

Bt pha hFn &G2h VD-10#3P-10

3(

10m%

tablet bao phim Hp 3 v x 10 vin VD-1##0-13

3$$0 m%

tablet bao phim VD-"03P3-13

74me :9$ :mlo&ipin Hp " v x 1$ vin,Hp 3 v x 10 vin,Hp 10 v x 1( vin

)n% t4 2< ph=n 74mephar2o8

Bihasal $ Bisoprolol fumarat )n% t4 56HH Hasan-Dermapharm8

:tenolol Uta&a $0m% :tenolol$0m%


5/9*5:O/D/6U5:D: 3$m% 9

5rimetaZi&in&ih4&ro2lori&K

Hp 3 v x 10 vin,Hp v x 10 vin


7`9* D/:7. 9 Nli2laZi& tablet t[2 &n% Wo&'i

Hp 3 v x "0 vinKHp " v x 30 vin

/rbesartan 1$0m% /rbesartan )n% t4 2< ph=n xuct nhMpWh@u 4 td Domes2o8

)lopi&o%rel P$m%At>In% Rn% vi)lopi&o%relbisulphat#P,!$Pm%

Hp 3 v x 10 vin,Hp ( v x P vin

)n% t4 2< ph=n &>?2 [email protected]

)larithrom42inD67harm $00

)larithrom42in Hp 1 v, 3 v, v, 10v, "$ v, $0 v x 10 vin)hai "0 vin, 0 vin,100 vin, "00 vin, $00vin

)n% t4 2< ph=n sn xuct -th>In% mCi D>?2 ph@m n%6am8

H:+/Q/9 100 )efixim Hp "( %i x 1,$% thu2 )n% t4 2< ph=n &>?2 HMuNian%8

osuvastatin Uta&a10m%

osuvastatin 10m% A&>i &Cn%osuvastatin2al2ium


;osartan Uta&a $0m% ;osartan Wali Hp 3 v x 10 vinKHp 10 v x 10 vin



5/16

Trang 5 / 16


3 tablet bao phim VD-"0!03-1(

3P tablet bao phim Hp 3 v x 10 vin VD-1(01-11

3! tablet sSi bTt8 VD-11!!-10 )n% t4 2< ph=n U87898

3# tablet Hp " v x 10 vin VD-"0$P(-1(

(0 tablet Hp " v x 10 vin VD-"0$P(-1(

(1"$0m%

poE&er sSi bTt Hp "( %i x 1,$% VD-"0$$!-1(

("1$0m%

poE&er sSi bTt Hp "( %i x 1,$% VD-"113P-1(

(3 Oin2ap $00

$00m%

tablet bao phim VD-"11#1-1(

(( 9i&an2ef 1"$1"$m%

tablet bao phim VD-"13""-1(

($ guin2ef 1"$m%$ml

1"$m%$ml

VD-"1(33-1(

( )a&iroxim $00

$00 m%

tablet bao phim Hp " v, v x $ vin VD-"1$!0-1(

Oeloxi2am P,$ 9eloxi2amP,$m%

Hp " v x 10 vin,Hp ( v x P vinK

)n% t4 2< ph=n D>?2 [email protected]

Valsartan U5:D:!0m%K

Valsartan!0m%


94para 7ara2etamol$00m%

Hp 1 tup x 10 vinHp " tup x 10 vinHp ( v x ( vin

9*B/;:Q 1$ 9eloxi2am1$m%


9*B/;:Q P,$ 9eloxi2amP,$m%


Hapa2ol "$0 7ara2etamol )n% t4 56HH 95V D>?2ph@m DHN8

Hapa2ol 1$0 7ara2etamol )n% t4 56HH 95V D>?2ph@m DHN8

)efuroxim $00m%A&>i &Cn%)efuroxim axetil

Hp 1 v x 10 vinK Hp" v x $ vin

)hi nh[nh 2n% t4 2< ph=n:rmepha2o- Q\ n%hi]p &>?2ph@m 1$08

)efuroxim 1"$m%A&>i &Cn%)efuroxim axetil

Hp 1 tXi x 1 v x 10vin )n% t4 2< ph=n &>?2 ph@m9inh DYn8

)efuroxim1"$m%$ml A&>i&Cn% )efuroximaxetil

Bt pha hFn &G2hun%

Hp 1 2hai 3!% bt phahFn &G2h un%

)n% t4 2< ph=n ho[ - &>?2ph@m 9eWophar8

)efuroxim $00 m%A&>i &Cn%)efuroxim axetil

)n% t4 56HH U 7harmaU:8


6/16

Trang 6 / 16


(P )efixim (00

(00 m%

tablet bao phim Hp 1 v, " v x 10 vin VD-"1$!3-1(

(! Dom-9onteluWast (

( m%

tablet nhai Hp 1 v, " v x 10 vin VD-"1(0-1(

(#

10m%

tablet bao phim Hp 3 v x 10 vin VD-"1(1-1(

$0 9onte%ol (

(m%

tablet nhai Hp 1 v, " v x 10 vin VD-"1($-1(

$1 eto2rom $00 )larithrom42in$00m%

tablet bao phim Hp $ v x vin VD-"1P0-1(

$" ;omepen $00 )larithrom42in$00m%

tablet bao phim VD-"1P3-1(

$3 9etoZamin $00 9etformin H)l$00m%

tablet bao phim VD-"1P$-1(

$( .Zaform $00 9etformin H)l$00m%

tablet bao phim VD-"1!0-1(

)efixim (00 m%A&>i &Cn% 2efiximtrih4&rat


9onteluWast ( m%A&>i &Cn%9onteluWast natri

)n% t4 2< ph=n &>?2 ph@mNlome&A)U6gj Dominion

7harma2al, JGa 2hj 111,:venue o4almount, Uuite100, 9ontreal, guebe2)ana&a, H(7 "5(

Dom-9onteluWast+)

9onteluWast 10 m%A&>i &Cn%9onteluWast natri

)n% t4 2< ph=n &>?2 ph@mNlome&8A)U6gj Dominion7harma2al, JGa 2hj 111,:venue o4almount, Uuite100, 9ontreal, guebe2)ana&a, H(7 "5(

9onteluWast ( m%A&>i &Cn%9onteluWast natri



Hp $ v x vinK hp10 v x vin


Hp 1 v x 10 vinK hp" v x 10 vin


Hp 1 v x 10 vinK hp" v x 10 vin



7/16

Trang 7 / 16


$$ :Zihasan 1"$

1"$m%

Hp %i, 30 %i x 1,$% VD-"1P-1(

$ Nlumeform $00$00m%

tablet bao phim Hp 10 v x 10 vin VD-"1PP#-1(

$P )efixim (00 tab

(00m%

tablet bao phim VD-"1P#1-1(

$! +i2emix (00

(00m%

tablet bao phim VD-"1P#"-1(

$# :pitim $

$m%

2apsule 2Rn% Hp 3 v x 10 vin VD-"1!11-1(

0 9onte%ol +)

10m%

tablet bao phim Hp 3 v x 10 vin VD-"1!(0-1(

1 :Zi2rom "$0

"$0m%

tablet bao phim Hp 1 v x vin VD-"1!P1-1(

" )larithro $00 )larithrom42in$00m%

tablet bao phim VD-"1#13-1(

3 )larivi&i $00 )larithrom42in$00m%

tablet bao phim VD-"1#1(-1(

:Zithrom42in 1"$m% A&>i &Cn%:Zithrom42in&ih4&rat

Bt pha hFn &G2hun%

)n% t4 56HH Ha san-Dermapharm8

9etforminh4&ro2lori& $00

m%


)efixim (00 m%A&>i &Cn%)efixim trih4&rat

Hp " v x $ vinK Hp1 v, 3 v x 10 vin


)efixim (00 m%A&>i &Cn%)efixim trih4&rat

Hp " v x $ vinK Hp1 v, 3 v x 10 vin


:mlo&ipin $ m%A&>i &Cn%:mlo&ipin besilat,# m%

)n% t4 2< ph=n D>?2 HMuNian%8

9onteluWast 10 m%A&>i &Cn%9onteluWast natri


:Zithrom42in"$0m% A&>i &Cn%:Zithrom42in&ih4&rat


Hp 1 v x 10 vinK hp10 v x 10 vinK hp 12hai 100 vin

)hi nh[nh 2n% t4 2< ph=n&>?2 ph@m trun% >In%Vi&ipha8

Hp " v x 10 vinK hp1 2hai 100 vin

)hi nh[nh 2n% t4 2< ph=n&>?2 ph@m trun% >In%Vi&ipha8


8/16

Trang 8 / 16


( 7etrimet 9 5rimetaZi&in H)l

3$m%

VD-""0$!-1(

$

)e&onWit "$0 "$0m% tablet bao phim V6-1!"("-1( Delta 7harma ;imite&8

1000m% tablet bao phim Hp 3 v x 10 vin V6-1!"#"-1(

P;ufixime (00 )efixim (00m% tablet bao phim Hp 1 v x vin V6-1!1(0-1( ;upin ;t&8


9/16

Trang 9 / 16

NAM

Add0+%% o' *,1',c&10+0 N,&$o

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

015

U 1, >^n% s P, )6 Vi]t6am - Uin%apore //, 78 Ha 7hX85p8 5hS D=u 9t, Bknh D>In%8

U 1, >^n% s P, )6 Vi]t6am - Uin%apore //, 78 Ha 7hX85p8 5hS D=u 9t, Bknh D>In%8

U "P, J>^n% 3:, hu 2n%n%hi]p Bin Ha ", n% 6ai8

1P 6%u4n Vn 5rFi, 7h>^n% 1",guMn 7hX 6huMn, 5p8 H )h\9inh8

"!! Bis 6%u4n Vn ), 78 :nHa, g8 6inh iu, 5p8 )=n5hI8


10/16

Trang 10 / 16

Add0+%% o' *,1',c&10+0 N,&$o

Vi]t 6am

Vi]t 6am

Vi]t 6am

Nerman4

:usrtria

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

1P 6%u4n Vn 5rFi, 7h>^n% 1",guMn 7hX 6huMn, 5p8 H )h\9inh8

hu 2n% n%hi]p 6hIn 5rC2h,hu4]n 6hIn 5rC2h, tnh n%6ai8

; *", 6(, hu 2n% n%hi]pHa Q[, tnh 6am Gnh8

5empelhofer qe% !3, D-1"3(P,Berlin, Nerman48

10 Bio2hemiestrase, :-"$0un&l-:ustria8

U 1P, 6%u4n Vn 5rFi, 781",guMn 7hX 6huMn, 5p8 H )h\9inh8

U 11" 5r=n H>n% Co, guMn 1,

5p8 H )h\ 9inh8

((!B 6%u4n 5ct 5h'nh, 71!,g(, 5p8 H )h\ 9inh8

((!B 6%u4n 5ct 5h'nh, 71!,g(, 5p8 H )h\ 9inh8

hu 2n% n%hi]p 5Yn 7hX5hCnh, hu4]n )hYu 5h'nh :,tnh HMu Nian%8


11/16

Trang 11 / 16

Add0+%% o' *,1',c&10+0 N,&$o

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

1$ 2 Binh iu, 7h>^n% ",5p8 9 5ho, 5in Nian%8

1$ 2 Binh iu, 7h>^n% ",5p8 9 5ho, 5in Nian%8

; B1(-3, >^n% 613, hu)n% n%hi]p n% 6am, Hu4]n)S )hi, 5p8 H )h\ 9inh8

; 91, >^n% 63, hu 2n%n%hi]p Ha Q[, 5p8 6am Gnh,tnh 6am Gnh8

)6 6hIn 5rC2h, Hu4]n 6hIn5rC2h, 5nh n% 6ai8

>^n% s ", )6 n% :n,

hu4]n 5huMn :n, tnh BknhD>In%8

)6 6hIn 5rC2h 3, hu4]n 6hIn5rC2h, tnh n% 6ai8

U 1-1P0 6%u4n Hu], 5p85u4 Ha, 5nh 7hX n8

(0 Ci l 5 Do, )6 Vi]t 6am- Uin%apore, 5huMn :n, BknhD>In%8


12/16

Trang 12 / 16

Add0+%% o' *,1',c&10+0 N,&$o

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

U 1-1P0 6%u4n Hu], 5p85u4 Ha, 5nh 7hX `n8

>^n% s ", )6 n% :n,5huMn :n, 5nh Bknh D>In%8

(0 Ci l 5 Do, )6 Vi]t 6am- Uin%apore, 5huMn :n, Bknh

D>In%8(0 Ci l 5 Do, )6 Vi]t 6am- Uin%apore, 5huMn :n, BknhD>In%8

1-1P0 6%u4n Hu], 5p8 5u4Ha, tnh 7hX `n8

U , gu2 l 30, 7h>^n% 97hX, 5p8 )ao ;nh, tnh n%5h[p8

U "P, >^n% 3:, hu 2n%n%hi]p Bin Ha ", tnh n%6ai8

; ":, >^n% s 1:, )6 5Yn5Co, guMn Bknh 5Yn, 5p8 H )h\9inh8

"!! Bis 6%u4n Vn ), 78 Ha:n, g8 6inh iu, 5p8 )=n 5hI,tnh hMu Nian%8

(0 Ci l 5 Do, )6 Vi]t 6am- Uin%apore, 5huMn :n, BknhD>In%8

(0 Ci l 5 Do, )6 Vi]t 6am

- Uin%apore, 5huMn :n, BknhD>In%8


13/16

Trang 13 / 16

Add0+%% o' *,1',c&10+0 N,&$o

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

U "P, >^n% 3:, )6 BinHa, n% 6ai8

U (0, Ci l 5 &o, )6 Vi]t6am-Uin%apore, 5huMn :n, BknhD>In%8

; U $1, J>^n% U ", Whu )n%n%hi]p 5Yn 5Co, ph>^n% 5Yn5Co :, uMn Bknh 5Yn, 57 H)h\ 9inh8





11" 5r=n H>n% Co- guMn 1-578 H )h\ 9inh8

; *", J>^n% 6(, )6 Ha Q[,578 6am Gnh, tnh 6am Gnh8

"#P$ - ; 5h>^n% i]t - guMn11- 578 H )h\ 9inh8

; B1-10, >^n% D", )6 5Y4B2 )S )hi, 578 H )h\ 9inh8


14/16

Trang 14 / 16

Add0+%% o' *,1',c&10+0 N,&$o

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

; B1-10, >^n% D", )6 5Y4B2 )S )hi, 578 H )h\ 9inh8

3$ Ci l 5 &o, )6 Vi]t 6am- Uin%apore, tnh Bknh D>In%8



U "P J>^n% 3:, )6 Bin Ha", n% 6ai8

U "P J>^n% 3:, )6 Bin Ha", n% 6ai8

U "P J>^n% 3:, )6 Bin Ha", n% 6ai8

U "P J>^n% 3:, )6 Bin Ha", n% 6ai8


15/16

Trang 15 / 16

Add0+%% o' *,1',c&10+0 N,&$o

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

Vi]t 6am

>^n% s ", hu )n% n%hi]pn% :n, hu4]n 5huMn :n, tnhBknh D>In%8

)6 5Yn 7hX 5hCnh, Hu4]n)hYu 5h'nh :, 5nh HMu Nian%

; B1-10, >^n% D", )6 5Y4B2 )S )hi, 578 H )h\ 9inh8

; B1-10, >^n% D", )6 5Y4B2 )S )hi, 578 H )h\ 9inh8

"!! Bis 6%u4n Vn ) , 78 :nHo', g8 6inh iu, 578 )=n5hI8


U "P J>^n% 3:, )6 Bin Ha

", n% 6ai8

cp 5Yn Bknh, x 5Yn Hi]p, hu4]n5Yn 4n, Bknh D>In%8

cp 5Yn Bknh, x 5Yn Hi]p, hu4]n5Yn 4n, Bknh D>In%8


16/16

Trang 16 / 16

Add0+%% o' *,1',c&10+0 N,&$o

Vi]t 6am

Nollstrabe 1, !($"# 5ittmornin%8 Nerman4

/n&ia

B T=>?NG@ T=>?NG

T! X1D

U 1 VU/7 //, J>^n% s P, hu2n% n%hi]p Vi]t 6am-Uin%apore //, hu lin h?p )n%n%hi]p-DG2h v- thG BknhD>In%, ph>^n% Ha 7hX, 5p85hS D=u 9t, tnh Bknh D>In%8

5araWan&i, 7aWun&ia,ishore%anw8

Ban%la&esh

1#!-"0", 6eE /n&ustrial :rea6o8 ", 9an&i&eep ("0(, Dist8aisen, 978

Documents

B.E Announced List 10th